Citation Impact
Citing Papers
Infection, inflammation, height, and longevity
2005 Standout
Acute kidney injury
2012 Standout
Localization of dopamine-1 receptors along the microdissected rat nephron
1991
Interactions of Dopaminergic and Peptidergic Factors in the Control of Prolactin Release*
1990
Dopamine and noradrenaline control distinct functions in rodent microglial cells
2005
Schizophrenia
2009 Standout
Myocardial dysfunction in the patient with sepsis
2002
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Autoradiographic localization of dopamine DA‐1 receptors in the rat renal vasculature using [3H]‐SCH 23390 as a ligand
1990
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Shock, inflammation and PARP
2005
Cardioprotective effects of poly(ADP-ribose) polymerase inhibition
2005
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
Characterization of the dopamine receptor expressed by rat glomerular mesangial cells in culture
1992
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 Standout
Specific binding of 125I SCH 23982, a selective dopamine (D1) receptor ligand to plasma membranes derived from human kidney cortex
1989
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Oxidative stress and regional ischemia-reperfusion injury: the peroxynitrite–poly(ADP-ribose) polymerase connection
2003
Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors
2005
Recent Advances in the Development of Novel Pharmacological Agents for the Treatment of Cognitive Impairments in Schizophrenia
2007
Beneficial effects of PJ34 and INO-1001, two novel water-soluble poly(ADP-ribose) polymerase inhibitors, on the consequences of traumatic brain injury in rat
2005
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
1990 StandoutNature
Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SK&F 38393
1987 StandoutNobel
Role of poly(adenosine diphosphate???ribose) polymerase 1 in septic peritonitis
2003
Potential role of poly(adenosine 5′-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock
2006
Nephrotoxic Effects in High-Risk Patients Undergoing Angiography
2003
Cardiorenal Syndrome
2008 Standout
Sepsis and septic shock
2018 Standout
Activation of Poly(ADP-Ribose) Polymerase Contributes to Development of Doxorubicin-Induced Heart Failure
2002
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Drugs acting on brain dopamine receptors: A conceptual re-evaluation five years after the first selective D-1 antagonist
1989
Dyslipidemia and inflammation: an evolutionary conserved mechanism
2005
Poly(ADP-ribose): novel functions for an old molecule
2006 Standout
EFFECT OF APOMORPHINE ON ADRENAL MEDULLARY CATECHOLAMINE LEVELS
1989
Acute dopaminergic influence on plasma adrenaline levels in the rat
1995 StandoutNobel
Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons
1995 StandoutNobel
Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications
1987
The Pathophysiology and Treatment of Sepsis
2003 Standout
Novel phenanthridinone inhibitors of poly(adenosine 5′-diphosphate-ribose) synthetase: Potent cytoprotective and antishock agents*
2002
Downregulation of the Drosophila Immune Response by Peptidoglycan-Recognition Proteins SC1 and SC2
2006 StandoutNobel
Bench-to-bedside review: Cytopathic hypoxia.
2002
Emerging drugs for the treatment of sepsis
2016
Binding of [3H]SCH23390 to a non-dopaminergic site in bovine kidney
1992
Evidence for a dopaminergic control of sympathoadrenal catecholamine release
1988
Reactive oxygen species, cellular redox systems, and apoptosis
2010 Standout
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
2007 Standout
Organic Azides: An Exploding Diversity of a Unique Class of Compounds
2005 Standout
Topoisomerase I inhibitors: camptothecins and beyond
2006 Standout
Role of poly(ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents
2002
Differential Regulation of Dopamine D1A Receptor Responsiveness by Various G Protein-coupled Receptor Kinases
1996 StandoutNobel
Two dopamine receptors: Biochemistry, physiology and pharmacology
1984
Dopaminergic mediation of the diuretic and natriuretic effects of ANF in the rat
1986
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Chiral 1,1-diaryl compounds as important pharmacophores
2013
The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats
1986 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
PTEN Activity Is Modulated During Ischemia and Reperfusion
2005 StandoutNobel
Luminescent Chemodosimeters for Bioimaging
2012 Standout
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
Thieno[3,2-b]- and Thieno[2,3-b]pyrrole Bioisosteric Analogues of the Hallucinogen and Serotonin Agonist N,N-Dimethyltryptamine
1999
Reversible Near-Infrared Fluorescent Probe Introducing Tellurium to Mimetic Glutathione Peroxidase for Monitoring the Redox Cycles between Peroxynitrite and Glutathione in Vivo
2013 Standout
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
The D-1 Dopamine Receptor and the Search for its Functional Role: From Neurochemistry to Behaviour
1987
Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine and piribedil by Rhesus monkeys
1986
Dopamine receptors: applications in clinical cardiology.
1985
Cellular and Molecular Mechanisms of Drug Dependence
1988 StandoutScience
One-Step Synthesis of Heterocyclic Privileged Medicinal Scaffolds by a Multicomponent Reaction of Malononitrile with Aldehydes and Thiols
2007
Drug Abuse: Hedonic Homeostatic Dysregulation
1997 StandoutScience
Radiohalogen incorporation into organic systems
2002
Artificial Molecular Machines
2015 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Cyclizations of N-Acyliminium Ions
2004 Standout
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
2011 Standout
Chiral Diarylmethanes via Copper-Catalyzed Asymmetric Allylic Arylation with Organolithium Compounds
2015 StandoutNobel
Invited review: Detoxifying endotoxin: time, place and person
2005
Poly(ADP-ribose) (PAR) polymer is a death signal
2006 Standout
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
2011 Standout
MODULATION OF ADRENAL CATECHOLAMINE RELEASE BY DA2 DOPAMINE RECEPTORS IN THE ANAESTHETIZED DOG
1988
A Near-IR Reversible Fluorescent Probe Modulated by Selenium for Monitoring Peroxynitrite and Imaging in Living Cells
2011 Standout
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Synthesis of an Azasteroid Using an Acyl Iminium Ion-Initiated Tandem Cyclization
1996
Characterization of Dopamine Receptors Associated with Aldosterone Secretion in Rat Adrenal Glomerulosa*
1986
Conformational Analysis of D1 Dopamine Receptor Agonists: Pharmacophore Assessment and Receptor Mapping
1996
Synthesis of Benzo-Fused 1-Azabicyclo[m.n.0]alkanes via the Schmidt Reaction: A Formal Synthesis of Gephyrotoxin
2000
Dopamine Receptors: From Structure to Function
1998 Standout
Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms
2019
Physiology of Microglia
2011 Standout
Metal-Free Multicomponent Syntheses of Pyridines
2014 Standout
Pharmacological Options in the Treatment of Benign Prostatic Hyperplasia
1997
Works of Dana Glock being referenced
Protective effect of a novel, potent inhibitor of poly(adenosine 5′-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis*
2002
A PORCINE MODEL OF PERITONITIS AND BACTEREMIA SIMULATES HUMAN SEPTIC SHOCK
1996
RANDOMIZED, BLINDED, PLACEBO-CONTROLLED TRIAL OF TISSUE FACTOR PATHWAY INHIBITOR IN PORCINE SEPTIC SHOCK
1998
Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors
1999
Dihydrexidine: a new potent peripheral dopamine D1 receptor agonist
1993
Protein-free phospholipid emulsion treatment improved cardiopulmonary function and survival in porcine sepsis
2003
Specific dopamine D-1 and DA1 properties of 4-(mono- and -dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline and its tetrahydrothieno[2,3c]pyridine analog
1987
Selective DA2 versus DA1 antagonist activity of domperidone in the periphery
1983
Dopamine agonist properties of N-alkyl-4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines
1981
Separation of peripheral dopamine receptors by a selective DA1 antagonist, SCH 23390.
1984
C(2)-Methylation abolishes DA1 dopamine agonist activity of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (6,7-ADTN): steric intolerance by the receptor
1984
Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism
1986
Synthesis of 2-(alkylamino)-5,6- and -6,7-dihydroxy-3,4-dihydroquinazolines and evaluation as potential dopamine agonists
1982
Synthesis of a radiobrominated analog of SCH 23390, a selfctive dopamine D1/DA1 antagonist
1986